nasdaq edit stock forecast

In this video clip from. About Editas Medicine Inc.

Buy These 3 Stocks Before They Pop Over 50 Say Analysts Nasdaq

The full extension of this triangle using the 1618 gives us 213 dollars as the final take profit.

. The average price target is 000 with a high estimate of 000 and a low estimate of 000. Close price at the end of the last trading day Thursday 11th Aug 2022 of the EDIT stock was 1809. It is engaged in.

On average analysts rate EDIT stock as a buy. During the day the stock fluctuated 882 from a day low at 1792 to a day high of 1950. This is 248 less than the trading day before Wednesday 10th Aug 2022.

ROKU is not having a good year in 2022. On average Wall Street analysts predict that Editas Medicine s share price could reach 4017 by Aug 4 2023. Earnings for Editas Medicine are expected to decrease in the coming year from 335 to 364 per share.

EDIT stock is to Buy EDIT stockOut of. The average of price targets set by Wall Street analysts indicates a potential upside of 649 in Editas EDIT. Editas Medicine Inc is a gene-editing company.

Society Pass Inc Nasdaq. If you had invested in Editas Medicine stock at 1820 your return over the last 6 years would have been 522 for an annualized return of 085 not including any dividends or dividend reinvestments. While the effectiveness of this highly sought-after metric is questionable the.

Based on our forecasts a long-term increase is expected the EDIT stock price prognosis for 2027-04-16 is 28373 USD. All forecasts are updated on daily basis. According to 6 Wall Street analyst s that have issued a 1 year EDIT price target the average EDIT price target is 4017 with the highest EDIT stock price forecast at 6500 and the lowest EDIT stock price forecast at 1700.

According to 23 stock analysts the average 12-month stock price forecast for EDIT stock is 3264 which predicts an increase of 10311. Forecast EDIT price target These targets are based on 21 analysts price predictions made in the past three months for EDIT over the next 12 months. According to 23 analysts the average rating for EDIT stock is Buy The 12-month stock price forecast is 3288 which is an increase of 16116 from the.

During the last trading day the stock fluctuated 1097 from a day low at 1468 to a day high of 1629. 26 rows NASDAQ predictions for August 2024. Holmesmichaelp Nov 9 2021.

LC have a very successful first quarter. The Editas Medicine Inc stock price fell by -885 on the last day Friday 26th Aug 2022 from 1627 to 1483. Based on analysts offering 12 month price targets for EDIT in the last 3 months.

May 29 2022 0730AM EDT. Editas Medicine NASDAQEDIT is scheduled to announce Q2 earnings results on Wednesday August 3rd before market open. Editas set for a homerun.

Nasdaq rebounds off key support at 11520768- resistance 12668 13506. Averaged NASDAQ value for month 12243. Over the last 1 year EDIT has beaten EPS estimates 75 of the time and has beaten revenue estimates 50 of the time.

Maximum value 12809 while minimum 11359. The consensus EPS Estimate is -080 12 YY and the consensus Revenue Estimate is 429M 10289 YY. The forecast for beginning of August 12720.

Sell candidate since 2022-08-18 Loss -696 PDF. Stock Price Forecast The 14 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 2750 with a high estimate of 8000 and a low estimate of 800. The company is grappling with the indirect consequences of the coronavirus pandemic including supply chain disruptions soaring inflation.

Editas looks ready to launch on the weekly with a bounce off support and 3x rsi hidden bullish divergence. Value at the end 12084 change for August -500. Editas Medicine has not formally confirmed its next earnings publication date but the companys estimated earnings date is Monday November 14th 2022 based off prior years report dates.

The lowest target is 808 and the highest is 84. Only mortgage rates forecast and history are updated weekly. According to the Trefis Machine Learning Engine which identifies trends in the companys stock price using six years of historical data returns for EDIT stock average around 26 in the next.

A variety of factors helped LendingClub NYSE. On average analysts forecast that EDITs EPS will be -341 for 2022 with the lowest EPS forecast at. The Editas Medicine Inc stock price fell by -132 on the last day Friday 8th Jul 2022 from 1520 to 1500.

Get the details here. Editas Medicine stock was originally listed at a price of 1820 in Feb 3 2016.

We Re Not Very Worried About Editas Medicine S Nasdaq Edit Cash Burn Rate Nasdaq